HELIOS UNDERWRITING PLC

Director's Dealing • Nov 8, 2021

National Storage Mechanism | Additional information

RNS Number : 5570R

Helios Underwriting Plc

08 November 2021

Helios Underwriting plc

("Helios", "Company" or the "Group")

Director's Shareholding 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, was informed on 5 November 2021 that, on the same day, The 1609 Fund Ltd, which is under the management of ILS Capital Management Ltd, a Company which Tom Libassi, Non-Executive Director of the Company, co-founded and is managing partner of, purchased 12,000 ordinary shares of 10 pence each ("Ordinary Shares") in the Company at 150 pence each. Mr Libassi is also a director of The 1609 Fund Ltd.

Following the completion of the above transaction, funds under management of, or associated with, ILS Capital Management Ltd, hold in aggregate 13,162,000 Ordinary Shares, representing approximately 19.17 per cent. of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transaction.

For further information please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive                                               +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer                               +44 (0)7754 965 917

Shore Capital (Nomad and Broker)

Robert Finlay                                                                              +44 (0)20 7408 4080

David Coaten    

Henry Willcocks

Willis Re Securities (Financial Adviser)

Alastair Rodger                                                                          +44 (0)20 3124 6033

Buchanan

Helen Tarbet / Henry Wilson / George Beale                      +44 (0)7872 604 453

+44 (0)20 7466 5111 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £131m of capacity for the 2021 account based on the LLV acquisitions completed to date in 2021. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Tom Libassi

2

Reason for the notification

a)

Position/status

Non-Executive Director, a PDMR of the issuer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN - GB00B23XLS45

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
Purchase: 150p	12,000

d)

Aggregated information

Price(s)	Volume(s)
Purchase: as above	As above

e)

Date of the transaction

5 November 2021

f)

Place of the transaction  

London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDELFBFFLBFBV